France· FR:63036718
PRIMALAN, sirop
A mequitazine product containing méquitazine, registered in France by PIERRE FABRE MEDICAMENT, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Mequitazine is registered in 2 of 19 countries.
Countries holding a registration under ATC R06AD07 (mequitazine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Mequitazine · ATC R06AD07
2 / 19 countries
- Franceprice
- Japan
Price per daily dose
What a daily dose of mequitazine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- France: $0.29 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mequitazine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- FR France$0.29
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉQUITAZINE
- Manufacturer
- PIERRE FABRE MEDICAMENT
- Country
- France (FR)
- ATC code
- R06AD07
- ATC class
- Mequitazine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009326368081 flacon(s) en verre teinté avec fermeture de sécurité enfant de 60 ml avec cuillère-mesureEUR 1.4
- cip1334009362730851 flacon(s) en verre teinté avec fermeture de sécurité enfant de 125 ml avec cuillère-mesureEUR 2.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R06AD07
Mequitazine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/235cca74-9eae-4a77-b5bc-55fda4f47a70 GET /v1/drugs/235cca74-9eae-4a77-b5bc-55fda4f47a70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63036718",
"date_amm": "1983-02-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MÉQUITAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "sirop",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about mequitazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.